PLX PHARMA INC. Trademark

Trademark Overview

On Tuesday, July 17, 2018, a trademark application was filed for PLX PHARMA INC. with the United States Patent and Trademark Office. The USPTO has given the PLX PHARMA INC. trademark a serial number of 88040660. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 4, 2022. This trademark is owned by PLx Pharma Inc.. The PLX PHARMA INC. trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans as anti-inflammatories, analgesics, antipyretics and for the prevention and treatment of cancer and for the prevention and treatment of cardiovascular and/or cerebrovascular disease
plx pharma inc.

General Information

Serial Number88040660
Word MarkPLX PHARMA INC.
Filing DateTuesday, July 17, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 1, 2019

Trademark Statements

Description of MarkThe mark consists of the wording "PLX PHARMA INC." all in white except for the lower left side line of the letter "X" which is in red. The background of the mark is in blue.
Goods and ServicesPharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans as anti-inflammatories, analgesics, antipyretics and for the prevention and treatment of cancer and for the prevention and treatment of cardiovascular and/or cerebrovascular disease
Indication of Colors claimedThe color(s) white, red, and blue is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMA INC."

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePLx Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSparta, NJ 07871
Party NamePLx Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77054

Trademark Events

Event DateEvent Description
Monday, April 4, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 25, 2021SOU EXTENSION 5 GRANTED
Friday, August 20, 2021SOU EXTENSION 5 FILED
Friday, August 20, 2021SOU TEAS EXTENSION RECEIVED
Friday, January 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 27, 2021SOU EXTENSION 4 GRANTED
Wednesday, January 27, 2021SOU EXTENSION 4 FILED
Wednesday, January 27, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 1, 2020SOU EXTENSION 3 GRANTED
Wednesday, August 26, 2020SOU EXTENSION 3 FILED
Wednesday, September 30, 2020NOTICE OF REVIVAL - E-MAILED
Tuesday, September 29, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, September 29, 2020PETITION TO REVIVE-GRANTED
Tuesday, September 29, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, September 28, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 28, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, August 28, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 28, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 28, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 19, 2020NOTICE OF REVIVAL - E-MAILED
Tuesday, May 19, 2020SOU EXTENSION 2 GRANTED
Wednesday, February 26, 2020SOU EXTENSION 2 FILED
Monday, May 18, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, May 18, 2020PETITION TO REVIVE-GRANTED
Monday, May 18, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, March 30, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 30, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 12, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 12, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2019SOU EXTENSION 1 GRANTED
Monday, August 26, 2019SOU EXTENSION 1 FILED
Wednesday, November 6, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 14, 2019NOTICE OF REVIVAL - E-MAILED
Monday, October 14, 2019SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, October 14, 2019PETITION TO REVIVE-GRANTED
Monday, October 14, 2019TEAS PETITION TO REVIVE RECEIVED
Monday, September 30, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 30, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 1, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 12, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 26, 2018ASSIGNED TO LIE
Tuesday, November 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 6, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, November 6, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 6, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, November 6, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, November 5, 2018ASSIGNED TO EXAMINER
Saturday, July 21, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, July 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 20, 2018NEW APPLICATION ENTERED

Related Keywords

pharma treatment prevention analgesics antipyretics cancer disease cerebrovascular cardiovascular inflammatories anti